Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Animalgesic Labs

Animalgesic Labs
Out of Business LATEST DEAL TYPE

Developer of a drug delivery system designed to provide treatment to animals. The company's drug delivery system develops a buprenorphine extended-release injectable suspension, enabling vets to control the post-procedural pain in mice and rats.

Formerly Known As
Bamvet Laboratories, Baltimore Animal Medicine
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Primary Office
  • 1121 Benfield Boulevard
  • Suite Q
  • Millersville, MD 21108
  • United States

+1 (410) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Animalgesic Labs’s full profile, request a free trial.

Animalgesic Labs Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Out of Business 01-Sep-2016 00000 Completed Out of Business
5. Grant 04-Jun-2013 00000 00000 Completed Generating Revenue
4. Early Stage VC 12-Feb-2008 00000 00000 Completed Startup
3. Grant 31-Jan-2008 0000 000.00 Completed Startup
2. Accelerator/Incubator 13-Aug-2007 $95.5K $95.5K Completed Startup
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Animalgesic Labs Executive Team (3)

Name Title Board
David Allen Chief Executive Officer & Co-Founder
Michael Guarnieri Ph.D Chief Scientific Advisor and Co-Founder

1 Former Executive

You’re viewing 2 of 3 executives. Get the full list »

Animalgesic Labs Board Members (1)

Name Representing Role Since Contact
Brian Cassell Self Board Member 000 0000